Traditional Chinese medicine compound extract for improving immune activity of organism as well as preparation method and application of traditional Chinese medicine compound extract

Through compound extracts composed of Chinese medicines such as Codonopsis pilosula, Astragalus, Polygonatum, Peony and other Chinese medicines, the side effects and efficiency of existing Western medicines and Chinese medicine immune enhancers have been solved, and the immune function has been significantly improved, providing a safe and efficient Chinese medicine immune enhancement. agent.

CN118903316APending Publication Date: 2024-11-08CHINA WEST NORMAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410951467.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing Western medicines have obvious side effects in improving immunity, and the safety and efficiency of most Chinese medicine immune enhancers are insufficient, so they cannot effectively deal with the problem of declining immune function in modern society.

Method used

Compound extracts composed of Chinese medicine such as Codonopsis pilosula, Astragalus, Polygonatum, Peony, Chuanxiong, Jujube, Licorice, Cinnamon, etc. are prepared through decoction and drying process to form a safe and efficient Chinese medicine compound extract for lifting the body. Immune vitality.

Benefits of technology

The Chinese medicine compound extract significantly improves immune function indicators, such as spleen index, lymphocyte proliferation ability, cytokine release and immunoglobulin IgG content, which has good safety and efficacy, and is better than the traditional Chinese medicine control group.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903316A_ABST
    Figure CN118903316A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine compound extract for improving body immune activity and a preparation method and application of the traditional Chinese medicine compound extract. The traditional Chinese medicine compound extract is prepared from radix codonopsis, radix astragali, rhizoma polygonati, Chinese herbaceous peony, rhizoma chuanxiong, fructus jujubae, radix glycyrrhizae and cortex cinnamomi. According to the traditional Chinese medicine compound extract, the organ index of immune organs of a mouse can be remarkably increased, the content of cell factors IL-2, IL-4, IFN-alpha and IFN-gamma in serum is increased, the phagocytic rate and the phagocytic index of chicken erythrocytes phagocytized by macrophages of the mouse are increased, and the preparation method of the traditional Chinese medicine compound extract is simple and suitable for large-scale production, popularization and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of traditional Chinese medicine, and in particular, relates to a traditional Chinese medicine compound extract for improving the immune activity of an organism, and a preparation method and application thereof. Background Art

[0002] Immune function is the body's ability to identify and eliminate foreign invading antigens and mutated or aging cells in the body, and to maintain the stability of the body's internal environment. The human immune system needs to identify and process self-antigens and foreign non-self antigens in the body to maintain the body's physiological balance. The body's immune stability function includes immune defense against infection, immune stability to stabilize the internal environment, and immune surveillance against tumors. If the immune stability function is abnormal, it will cause physiological disorders, cause excessive or low immune responses, and lead to the occurrence of various immune diseases.

[0003] Traditional Chinese medicine believes that the occurrence and development of immune diseases are closely related to factors such as insufficient congenital endowment, exogenous six evils, imbalance of Yingwei Qi and blood, dysfunction of internal organs, and endogenous phlegm and blood stasis. Studies on the immune regulation of traditional Chinese medicine have shown that traditional Chinese medicine plays an important role in the treatment of diseases. Pharmacological studies of traditional Chinese medicine have shown that some traditional Chinese medicines can enhance immunity by enhancing the body's immune function and promoting the physiological functions of lymphocytes, monocytes and macrophages, and hematopoietic stem cells. Studies have shown that organ indexes, B lymphocyte proliferation, spleen natural killer cell (NK) activity, cytokine IL-2, IL-4, TNF-γ, TNF-α and IgG release, and activation of CD4+ T cells can be observed. 4+ and CD 8+ Immune cell populations, lymphocyte counts, and levels of red blood cells, white blood cells, and macrophages in routine blood tests are important indicators of changes in immune function.

[0004] With the development of economy, the pace of life in modern society is accelerating, people have great work pressure and irregular living habits, and the number of sub-healthy people is increasing day by day, which leads to the decline of body immune function and frequent occurrence of various chronic diseases. More and more people are gradually aware of the importance of immunoregulation in body health, and improving body immunity has become the main trend of disease prevention. However, most of the existing Western medicines that can improve immunity on the market are for certain immune diseases, and the side effects are obvious. Based on the relationship between traditional Chinese medicine theory and the immune system, coupled with the fact that most Chinese medicines have little or no toxic side effects, researching and developing safe and efficient Chinese medicine immunopotentiators is an urgent requirement for the development of the times, and it is also an inevitable trend for the development of the big health industry, which has very important practical significance. This application provides a Chinese medicine compound extract and a preparation method thereof for improving body immune activity through research, and the Chinese medicine compound extract prepared by the method has a good effect of improving body immunity. Summary of the invention

[0005] In view of the deficiencies in the above-mentioned prior art, the purpose of the present invention is to provide a new Chinese herbal compound extract for improving the body's immune activity and its preparation method and application. The Chinese herbal compound extract provided by the present invention has been verified by animal experiments and has a good effect of enhancing the body's immune activity.

[0006] The present invention adopts the following technical solutions to achieve the above-mentioned invention objectives:

[0007] The first aspect of the present invention provides a Chinese herbal compound extract for improving the immune activity of the body.

[0008] Furthermore, the Chinese medicine compound extract is composed of Codonopsis pilosula, Astragalus membranaceus, Polygonatum sibiricum, Paeonia lactiflora, Ligusticum chuanxiong, Jujube, Licorice and Cinnamon bark.

[0009] Furthermore, the Chinese medicine compound extract is composed of the following components in parts by weight: 10-30 parts of Codonopsis pilosula, 10-30 parts of Astragalus membranaceus, 10-40 parts of Polygonatum sibiricum, 5-15 parts of Paeonia lactiflora, 5-15 parts of Ligusticum chuanxiong, 1-10 parts of jujube, 2-10 parts of Licorice, and 2-8 parts of Cinnamon bark.

[0010] Furthermore, the Chinese medicine compound extract is composed of the following components in parts by weight: 12-28 parts of Codonopsis pilosula, 12-28 parts of Astragalus membranaceus, 12-38 parts of Polygonatum sibiricum, 6-14 parts of Paeonia lactiflora, 6-14 parts of Ligusticum chuanxiong, 2-8 parts of jujube, 2-8 parts of Licorice, and 2-7 parts of cinnamon.

[0011] Furthermore, the Chinese medicine compound extract is composed of the following components by weight: 14-24 parts of Codonopsis pilosula, 16-24 parts of Astragalus, 16-36 parts of Polygonatum sibiricum, 8-12 parts of Paeonia lactiflora, 8-12 parts of Chuanxiong, 2-6 parts of jujube, 4-6 parts of Licorice, and 2-6 parts of Cinnamon;

[0012] Optionally, the Chinese medicine compound extract is composed of the following components in parts by weight: 20 parts of Codonopsis pilosula, 20 parts of Astragalus, 20 parts of Polygonatum sibiricum, 10 parts of Peony, 10 parts of Chuanxiong, 5 parts of Jujube, 5 parts of Licorice, and 3 parts of Cinnamon;

[0013] Optionally, the Chinese medicine compound extract is composed of the following components by weight: 15 parts of Codonopsis pilosula, 20 parts of Astragalus, 30 parts of Polygonatum sibiricum, 8 parts of Paeonia lactiflora, 8 parts of Chuanxiong, 2 parts of jujube, 4 parts of Licorice, and 6 parts of Cinnamon;

[0014] Optionally, the Chinese medicine compound extract is composed of the following components in parts by weight: 14 parts of Codonopsis pilosula, 18 parts of Astragalus membranaceus, 24 parts of Polygonatum sibiricum, 8 parts of Paeonia lactiflora, 10 parts of Ligusticum chuanxiong, 6 parts of Jujube, 6 parts of Licorice, and 5 parts of Cinnamon.

[0015] In some embodiments, the Codonopsis pilosula includes but is not limited to the dried rhizomes of Codonopsis pilosula (Franch.) Nannf., Codonopsis pilosula Nannf. var. modesta (Nannf.) LTShen or Codonopsis tangshen Oliv. of the Campanulaceae family.

[0016] In some embodiments, the meridians of the Codonopsis pilosula include but are not limited to: spleen meridian and lung meridian, and its functions include but are not limited to: tonifying the middle and replenishing qi, strengthening the spleen and benefiting the lungs.

[0017] In some embodiments, the astragalus includes but is not limited to: the dried root of Astragalusmembranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Astragalusmembranaceus (Fisch.) Bge. of the Leguminosae family.

[0018] In some embodiments, the meridians of the Astragalus include but are not limited to: spleen meridian and lung meridian, and its functions include but are not limited to: tonifying qi and strengthening the exterior, promoting diuresis and detoxification, draining pus, and healing sores and promoting tissue regeneration.

[0019] In some embodiments, the polygonatum includes but is not limited to: dried rhizomes of Polygonatumkingianum Coll. et Hemsl., Polygonatum sibiricum Red., or Polygonatum cyrtonema Hua, plants of the Liliaceae family.

[0020] In some embodiments, the meridians of the Polygonatum sibiricum include but are not limited to: spleen meridian, lung meridian, kidney meridian, and its functions include but are not limited to: tonifying qi and nourishing yin, strengthening the spleen, moistening the lungs, and benefiting the kidneys.

[0021] In some embodiments, the peony includes but is not limited to: the dried root of Paeonialactiflora Pall. of the Ranunculaceae family.

[0022] In some embodiments, the meridians of the peony include but are not limited to: liver meridian and spleen meridian, and its functions include but are not limited to: calming the liver and relieving pain, nourishing blood and regulating menstruation, and astringing yin and stopping sweating.

[0023] In some embodiments, the Ligusticum chuanxiong includes but is not limited to: dried rhizomes of the plant Ligusticum chuanxiong Host. of the Umbelliferae family.

[0024] In some embodiments, the meridians of Chuanxiong include but are not limited to: liver meridian, gallbladder meridian, pericardium meridian, and its functions include but are not limited to: promoting blood circulation, removing blood stasis, and dispelling wind and relieving pain.

[0025] In some embodiments, the jujube includes but is not limited to: dried mature fruits of Ziziphus jujuba Mill. var. inermis (Bunge) Rehd. of the Rhamnaceae family.

[0026] In some embodiments, the meridians of the jujube include but are not limited to: spleen meridian and stomach meridian, and its functions include but are not limited to: tonifying the middle and replenishing qi, nourishing blood and calming the mind.

[0027] In some embodiments, the licorice includes but is not limited to: dried roots of Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., or Glycyrrhiza glabra L. of the Leguminosae family.

[0028] In some embodiments, the meridians of the licorice include but are not limited to: heart meridian, lung meridian, spleen meridian, stomach meridian, and its functions include but are not limited to: tonifying the spleen and replenishing qi, clearing away heat and detoxifying, removing phlegm and relieving cough, relieving acute pain, and harmonizing various medicines.

[0029] In some embodiments, the cinnamon includes but is not limited to: dried bark of Cinnamomum cassia Presl, a plant of the Lauraceae family.

[0030] In some embodiments, the meridians of cinnamon bark include but are not limited to: kidney meridian, spleen meridian, heart meridian, liver meridian, and its functions include but are not limited to: replenishing fire and yang, guiding fire back to its source, dispelling cold and relieving pain, and promoting blood circulation and unblocking menstruation.

[0031] The second aspect of the present invention provides a pharmaceutical preparation for improving the immune activity of an organism.

[0032] Furthermore, the active ingredient of the pharmaceutical preparation is the Chinese herbal compound extract described in the first aspect of the present invention.

[0033] Furthermore, the pharmaceutical preparation contains pharmaceutically or food-acceptable excipients;

[0034] Optionally, the dosage form of the pharmaceutical preparation includes granules, tablets, pills, capsules, solutions or suspensions.

[0035] When preparing the pharmaceutical preparation of the present invention, the active ingredients of the present invention are added to pharmaceutically or food-acceptable excipients, and conventional preparation preparation techniques well known to those skilled in the art are used to prepare the pharmaceutical preparation routinely required in clinical practice.

[0036] It should be noted that the present invention has no particular limitation on the dosage form of the pharmaceutical preparation, and any pharmaceutical preparation prepared with the Chinese herbal compound extract described in the first aspect of the present invention as an effective ingredient is within the protection scope of the present invention.

[0037] In some embodiments, the pharmaceutically or food-acceptable excipients are excipients required for preparing various pharmaceutical dosage forms, and the pharmaceutically or food-acceptable excipients include but are not limited to fillers, disintegrants, surfactants, binders, and lubricants.

[0038] Exemplarily, the filler includes, but is not limited to, starch, sorbitol, dextrin, lactose, microcrystalline cellulose, mannitol, pregelatinized starch, and the like.

[0039] Exemplarily, the disintegrant includes, but is not limited to, sodium carboxymethyl starch, cross-linked sodium carboxymethyl cellulose, cross-linked polyvinylpyrrolidone, hydroxypropyl cellulose, and the like.

[0040] Illustratively, the surfactant includes, but is not limited to, sodium dodecyl sulfate, oleic acid, stearic acid, sodium hexadecyl sulfate, lauric acid, and the like.

[0041] Exemplarily, the adhesive includes, but is not limited to, starch slurry, hydroxypropyl methylcellulose, sodium starch slurry, povidone, and the like.

[0042] Exemplarily, the lubricant includes, but is not limited to, talc, magnesium stearate, polyethylene glycol, and the like.

[0043] In some embodiments, the pharmaceutically or food-acceptable excipients may also include any one or more of suspending agents, solubilizing agents, flavoring agents, preservatives, antioxidants, stabilizers, and the like.

[0044] Exemplarily, the suspending agent includes, but is not limited to, gum arabic, hydroxypropyl cellulose, methyl cellulose, gum tragacanth, peach gum, sodium carboxymethyl cellulose, silica bentonite, and the like.

[0045] Exemplarily, the cosolvent includes, but is not limited to, lactobionic acid, malic acid, hydrochloric acid, acetic acid, lactic acid, phosphoric acid, glucoheptonic acid, propionic acid, boric acid, glucuronic acid, gluconic acid, citric acid, tartaric acid, threonic acid, 2,5-dihydroxybenzoic acid, acidic amino acids, and the like.

[0046] Exemplarily, the flavoring agents include, but are not limited to, cyclamate, sorbitol, mannitol, saccharin sodium, acesulfame-K, aspartame, glycerol, sucrose, simple syrup, aromatic syrup, and the like.

[0047] Exemplarily, the preservatives include, but are not limited to: sorbic acid and its salts, phenol, chlorocresol, cresol, thymol, benzoic acid and its salts, propionic acid, formaldehyde, boric acid and its salts, phenylethyl alcohol, chlorobutanol, glutaraldehyde, benzyl alcohol, chloroform, chlorhexidine, etc.

[0048] Exemplarily, the antioxidants and stabilizers include, but are not limited to, thiosulfate, sulfurous acid, glutathione, dimercaptopropanol, bisulfite, sulfite, pyrosulfite, dithionite, gallic acid and salts, thiourea, thioglycolic acid and salts, thiolactic acid and salts, thiodipropionic acid and salts, caffeic acid or its pharmaceutically acceptable salts, ferulic acid or its pharmaceutically acceptable salts, ascorbic acid and ascorbate, di-tert-butylparaphenol, nicotinamide, tartaric acid, phosphate, 2,5-dihydroxybenzoic acid or its salts, salicylic acid or its salts, isoascorbic acid and isoascorbate, pharmaceutically acceptable acetate, citrate, EDTA and EDTA salts, etc.

[0049] In some embodiments, the dosage form of the pharmaceutical preparation is an oral preparation, and the oral preparation dosage form includes granules, tablets, pills, capsules, solutions or suspensions.

[0050] In some embodiments, the granules are prepared by the following method: using the Chinese herbal compound extract described in the first aspect of the present invention as an active ingredient, adding pharmaceutical excipients, mixing, granulating, drying, and packaging to obtain Chinese herbal granules containing the Chinese herbal compound extract.

[0051] In some embodiments, the tablets are prepared by the following method: using the Chinese herbal compound extract described in the first aspect of the present invention as an active ingredient, drying, adding pharmaceutical excipients, mixing, granulating, drying, tableting, and coating to obtain Chinese herbal tablets containing the Chinese herbal compound extract. The tablets can be plain tablets or coated tablets, such as sugar-coated, gastric-coated, enteric-coated, etc.

[0052] In some embodiments, the pills are prepared by the following method: using the Chinese herbal compound extract described in the first aspect of the present invention as the active ingredient, after drying and crushing, adding pharmaceutical excipients, placing in a sugar coating pan, rotating the sugar coating machine, adding polar solvents, stirring, forming pills, drying, coating, and packaging to obtain Chinese herbal pills containing the Chinese herbal compound extract.

[0053] In some embodiments, the capsule is prepared by the following method: using the Chinese herbal compound extract described in the first aspect of the present invention as an active ingredient, drying, adding pharmaceutical excipients, mixing, granulating, drying, and encapsulating to obtain a Chinese herbal capsule containing the Chinese herbal compound extract. The capsule can be a hard capsule preparation or a soft capsule.

[0054] In some embodiments, the solution is prepared by the following method: using the Chinese herbal compound extract described in the first aspect of the present invention as the active ingredient, adding water and stirring to mix, then adding pharmaceutical excipients, stirring evenly, filtering, encapsulating, sterilizing, and packaging to obtain a Chinese herbal solution containing the Chinese herbal compound extract.

[0055] In some embodiments, the suspension is prepared by the following method: the Chinese herbal compound extract described in the first aspect of the present invention is used as an active ingredient, it is suspended in a dispersion medium, and then pharmaceutical excipients are added, stirred evenly, filled, sterilized, and packaged to obtain a Chinese herbal suspension containing the Chinese herbal compound extract.

[0056] The third aspect of the present invention provides a method for preparing the Chinese herbal compound extract according to the first aspect of the present invention.

[0057] Further, the method comprises the following steps:

[0058] (1) taking the raw material of the Chinese herbal compound extract, crushing and sieving;

[0059] (2) extracting by boiling and leaching with water 5-20 times the liquid-to-solid ratio or ethanol 80% or less by volume;

[0060] (3) filtering each extract in step (2), combining and concentrating the extract to obtain a concentrated solution of the Chinese herbal compound extract according to the first aspect of the present invention;

[0061] (4) The concentrated solution in step (3) is vacuum dried or spray dried to obtain the dry powder of the Chinese herbal compound extract according to the first aspect of the present invention.

[0062] Furthermore, the extraction conditions in step (2) are 1 to 4 extraction times, each time for 20 min to 180 min.

[0063] The fourth aspect of the present invention provides a method for preparing the pharmaceutical preparation according to the second aspect of the present invention.

[0064] Furthermore, the method comprises the following steps: mixing the Chinese herbal compound extract described in the first aspect of the present invention with pharmaceutically or food-acceptable auxiliary materials to obtain the pharmaceutical preparation described in the second aspect of the present invention.

[0065] The fifth aspect of the present invention provides the use of the Chinese herbal compound extract described in the first aspect of the present invention or the pharmaceutical preparation described in the second aspect of the present invention in the preparation of drugs, health products or foods for enhancing or improving the body's immune activity.

[0066] Compared with the prior art, the present invention has the following beneficial effects:

[0067] (1) Under the guidance of traditional Chinese medicine theory, the Chinese medicine compound extract provided by the present invention has the effects of nourishing the liver and kidney, regulating the spleen and stomach, replenishing both qi and blood, and harmonizing yin and yang through scientific and reasonable compatibility. The animal test results show that the Chinese medicine compound extract provided by the present invention has a good effect of enhancing the body's immunity, and the raw materials are all medicinal materials that are both medicinal and edible or can be used for health care products, with good efficacy, low toxic and side effects, and safe clinical use. The present invention provides a new idea and strategy for the technical field of improving the body's immune activity, and has good clinical application prospects.

[0068] (2) The present invention has verified through comparative experiments that the effect of the Chinese herbal compound extract provided by the present invention (consisting of Codonopsis pilosula, Astragalus membranaceus, Polygonatum sibiricum, Paeonia lactiflora, Chuanxiong rhizome, jujube, licorice, and cinnamon bark) on improving immunity is significantly better than that of the Chinese herbal control group extract (consisting of Codonopsis pilosula, Astragalus membranaceus, Rehmannia glutinosa, Atractylodes macrocephala, Chuanxiong rhizome, jujube, licorice, and cinnamon bark). After replacing the Chinese herbal medicines "Rehmannia glutinosa" and "Atractylodes macrocephala" with "Polygonatum sibiricum" and "Paeonia lactiflora", the effect of improving immunity can be significantly enhanced. This result is a technical effect that is unexpected by the technicians in this field based on the prior art. BRIEF DESCRIPTION OF THE DRAWINGS

[0069] Figure 1 The effect of Chinese medicine compound extract on the immune organ index of mice, compared with the model group, **p<0.01; compared with the Chinese medicine control group, #p<0.05, ##p<0.01;

[0070] Figure 2 The effect of Chinese medicine compound extract on the proliferation of mouse spleen lymphocytes, compared with the model group, *p<0.05, **p<0.01; compared with the Chinese medicine control group, #p<0.05, ##p<0.01;

[0071] Figure 3 This is the effect of the Chinese medicine compound extract on the content of immunoglobulin IgG in mouse serum. Compared with the model group, *p<0.05, **p<0.01; compared with the Chinese medicine control group, #p<0.05, ##p<0.01. DETAILED DESCRIPTION

[0072] The present invention is further described below in conjunction with specific embodiments, which are only used to explain the present invention and cannot be understood as limiting the present invention. It can be understood by those skilled in the art that various changes, modifications, substitutions and variations can be made to these embodiments without departing from the principles and purpose of the present invention, and the scope of the present invention is defined by the claims and their equivalents.

[0073] The drugs and raw materials used in the present invention are easily available to those of ordinary skill in the art. Unless otherwise specified, they can be obtained from commercial sources. The experimental methods for which specific conditions are not specified in the present invention are usually tested under conventional conditions or under conditions recommended by the manufacturer. In particular, the following examples are only used to illustrate the present invention and should not limit the scope of the present invention in any way. It should be noted that the specific weight ratios of the raw materials, process conditions and results described in the following examples are only used to illustrate the present invention, and should not and will not limit the present invention described in detail in the claims.

[0074] Example 1 Preparation of Chinese herbal compound extract (T-1)

[0075] Preparation of raw materials: Crush the dried Chinese medicinal raw materials of Codonopsis pilosula, Astragalus membranaceus, Polygonatum sibiricum, Paeonia lactiflora, Ligusticum chuanxiong, Jujube, Licorice and Cinnamon bark respectively, sieve through 40 meshes respectively, and seal and store at room temperature for later use.

[0076] Preparation of Chinese herbal compound extract: Take 20 parts of Codonopsis pilosula, 20 parts of Astragalus membranaceus, 20 parts of Polygonatum sibiricum, 10 parts of Paeonia lactiflora, 10 parts of Chuanxiong, 5 parts of Jujube, 5 parts of Licorice, and 3 parts of Cinnamon respectively by weight, mix them evenly, add distilled water in an amount 10 times the weight of the medicinal materials, extract twice by decoction, each time for 40 minutes, combine the extracts, concentrate under reduced pressure at 70°C, and dry under reduced pressure at 60°C to obtain a powder, which is the prepared Chinese herbal compound extract (T-1).

[0077] Example 2 Preparation of Chinese herbal compound extract (T-2)

[0078] Preparation of raw materials: Crush the dried Chinese medicinal raw materials of Codonopsis pilosula, Astragalus membranaceus, Polygonatum sibiricum, Paeonia lactiflora, Ligusticum chuanxiong, Jujube, Licorice and Cinnamon bark respectively, sieve through 40 meshes respectively, and seal and store at room temperature for later use.

[0079] Preparation of Chinese herbal compound extract: Take the above raw material powders according to weight proportions: 15 parts of Codonopsis pilosula, 20 parts of Astragalus, 30 parts of Polygonatum, 8 parts of Paeonia lactiflora, 8 parts of Chuanxiong, 2 parts of Jujube, 4 parts of Licorice, and 6 parts of Cinnamon respectively, mix them evenly, add distilled water in an amount 20 times the weight of the medicinal materials, extract by decoction for 3 times, each time for 80 minutes, combine the extracts, concentrate under reduced pressure at 70°C, and dry under reduced pressure at 60°C to obtain a powder, which is the prepared Chinese herbal compound extract (T-2).

[0080] Example 3 Preparation of Chinese herbal compound extract (T-3)

[0081] Preparation of raw materials: Crush the dried Chinese medicinal raw materials of Codonopsis pilosula, Astragalus membranaceus, Polygonatum sibiricum, Paeonia lactiflora, Ligusticum chuanxiong, Jujube, Licorice and Cinnamon bark respectively, sieve through 40 meshes respectively, and seal and store at room temperature for later use.

[0082] Preparation of Chinese herbal compound extract: Take the above raw material powders according to weight proportions: 14 parts of Codonopsis pilosula, 18 parts of Astragalus, 24 parts of Polygonatum, 8 parts of Paeonia lactiflora, 10 parts of Chuanxiong, 6 parts of Jujube, 6 parts of Licorice, and 5 parts of Cinnamon respectively, mix them evenly, add distilled water in an amount 15 times the weight of the medicinal materials, extract twice by decoction, each time for 60 minutes, combine the extracts, concentrate under reduced pressure at 70°C, and dry under reduced pressure at 60°C to obtain a powder, which is the prepared Chinese herbal compound extract (T-3).

[0083] Example 4 Verification and comparative test of the efficacy of the Chinese herbal compound extract of the present invention in improving the body's immunity

[0084] In order to test the efficacy of the Chinese herbal compound extract prepared by the present invention in improving the body's immunity, the following animal experiment was carried out.

[0085] The test drugs used in the following efficacy tests are the Chinese herbal compound extracts prepared in the above-mentioned Examples 1, 2 and 3, respectively, which are named T-1, T-2 and T-3, respectively.

[0086] The preparation method of the Chinese medicine control group extract used is as follows: replace the "Polygonatum sibiricum" and "Peony root" in the Chinese medicine compound provided by the present invention with the Chinese medicines "Rehmannia glutinosa" and "Atractylodes macrocephala" that have the function of improving immunity in turn, and prepare according to the proportion and preparation method in Example 1 to obtain the Chinese medicine control group extract.

[0087] 1. Animal testing1

[0088] Experimental animals and feeding conditions: SPF female Kunming mice were selected, aged 6-8 weeks, weighing 18-22g; the feeding temperature was 20-24℃, the humidity was 40-60%, the light was on for 12h and the light was off for 12h every day, the mice were fed and drank freely, and the mice were fed in a barrier system. Before the experiment, the mice were fed under the above conditions for one week to adapt to the environment.

[0089] Experimental groups: A total of 48 mice were raised and divided into 6 groups, with 8 mice in each group. The groups are as follows: blank control group, model group, Chinese medicine control group, T-1 group, T-2 group and T-3 group.

[0090] Experimental method: During the experiment, the mice were weighed every day, and the volume of intraperitoneal injection or gavage was 1% of the mouse body weight. After the mice adapted to the environment for 1 week, the blank control group was intraperitoneally injected with normal saline for 3 consecutive days, and the other groups were intraperitoneally injected with cyclophosphamide (80 mg / Kg BW) for 3 consecutive days to construct a mouse immunosuppression model. During the next 21 days of treatment, the blank control group and the model group were gavaged with normal saline, the Chinese medicine control group was gavaged with a dose of 200 mg / Kg BW of the Chinese medicine control group extract, the T-1 group was gavaged with a dose of 200 mg / Kg BW of the T-1 Chinese medicine compound extract solution, the T-2 group was gavaged with a dose of 200 mg / Kg BW of the T-2 Chinese medicine compound extract solution, and the T-3 group was gavaged with a dose of 200 mg / Kg BW of the T-3 Chinese medicine compound extract solution. After the gavage, all mice were fasted but not watered on the 24th day.

[0091] Measuring indicators:

[0092] (1) Determination of immune organ index: 24 h after the last oral administration, the mice were weighed and killed by cervical dislocation. The immune organs, spleen and thymus, were removed, washed with saline, dried with filter paper, and weighed. The immune organ index of the mice was calculated (expressed as the ratio of immune organ weight to mouse body weight, unit: mg / g).

[0093] (2) Determination of cytokine and immunoglobulin content: During dissection, the small intestinal tissue was removed and rinsed with physiological saline, and the surface moisture was dried with filter paper. An appropriate amount of small intestinal tissue was cut and added to 4°C PBS buffer, and a 10% tissue homogenate was prepared in an ice bath. After centrifugation, the supernatant was divided and stored in a -80°C refrigerator for later use. The secretion of cytokines TNF-α, IFN-γ, IL-2, IL-4, and IgG was detected by referring to the operating instructions of the corresponding ELISA kit.

[0094] (3) Assay of spleen lymphocyte proliferation activity: The spleen weighed above was cut into pieces, and a lymphocyte suspension was prepared in RPMI-1640 medium. The lymphocyte concentration was adjusted to 2×10 6 The diluted lymphocyte solution was transferred to a 96-well plate (100 μL / well), and the experimental group and the control group were set up, with 3 replicates in each group. Concanavalin A (ConA) with a final concentration of 5 μg / mL was added to the experimental group, and an equal volume of RPMI-1640 culture medium was added to the control group, and the cells were cultured in a cell culture incubator for 48 h (37°C, 5% CO 2 ), then add 20 μL of 5 mg / mL MTT to each well, incubate for 4 h, remove the culture medium, add 150 μL DMSO, shake for 100 min, measure the absorbance at 570 nm, and calculate the spleen lymphocyte proliferation rate according to the following formula:

[0095] Splenic lymphocyte proliferation rate (%) = absorbance value of test group / absorbance value of control group × 100%.

[0096] 2. Results of Animal Experiment 1

[0097] (1) The effects of the Chinese herbal compound extract of the present invention on the spleen and thymus Figure 1 As shown. The results showed that compared with the blank control group, the spleen and thymus indexes of the mice in the model group were extremely significantly reduced (p about 0.01), indicating that the modeling of this experiment was successful. Compared with the model group, the Chinese medicine control group, Example 1 (T-1 group), Example 2 (T-2 group) and Example 3 (T-3 group) of the present invention prepared Chinese medicine compound extracts can extremely significantly increase the spleen and thymus indexes of mice (p about 0.01); compared with the Chinese medicine control group, the immune activity of the T-1 group, T-2 group and T-3 group was significantly enhanced (p about 0.05).

[0098] (2) Effect of the Chinese herbal compound extract of the present invention on the proliferation capacity of mouse spleen lymphocytes Figure 2 The results of variance analysis showed that the proliferation capacity of spleen lymphocytes in the model group was significantly lower than that in the blank control group (p about 0.01); compared with the model group, the proliferation rate of spleen lymphocytes in the T-1 group, T-2 group and T-3 group mice was significantly increased (p about 0.01); compared with the Chinese medicine control group, the proliferation rate of spleen lymphocytes in the T-1 group, T-2 group and T-3 group mice was significantly increased (p about 0.05).

[0099] (3) The effects of the Chinese herbal compound extracts of the present invention on the levels of cytokines in mouse serum are shown in Table 1. Variance analysis showed that after continuous intraperitoneal injection of cyclophosphamide for 3 days, the levels of IL-2, IL-4, IFN-α and IFN-γ in the serum of mice in the model group were significantly lower than those in the blank control group (p about 0.01); compared with the model group, the levels of IL-2, IL-4, IFN-α and IFN-γ in the serum of mice in the T-1 group, T-2 group and T-3 group were significantly increased (p about 0.01). Compared with the Chinese medicine control group, the levels of IL-2, IL-4, IFN-α and IFN-γ in the serum of mice in the T-1 group, T-2 group and T-3 group were significantly increased (p about 0.05)

[0100] The effect of the Chinese herbal compound extracts of the present invention on the IgG content in mouse serum is as follows: Figure 3As shown in the figure. The variance analysis showed that the IgG content in the serum of the mice in the model group was significantly lower than that in the blank control group (p about 0.01); compared with the model group, the IgG content in the serum of the mice in the T-1 group, T-2 group and T-3 group was significantly increased (p about 0.01); the IgG content in the serum of the mice in the T-1 group, T-2 group and T-3 group was significantly higher than that in the Chinese medicine control group (p about 0.05).

[0101] Table 1 Effects of Chinese herbal compound extracts on cytokine levels in mouse serum

[0102]

[0103] Note: Compared with the model group, *p is about 0.05, **p is about 0.01; compared with the Chinese medicine control group, #p is about 0.05, ##p is about 0.01.

[0104] 3. Animal testing 2

[0105] The ability of mouse peritoneal macrophages to phagocytose chicken red blood cells was determined by a semi-in vivo method. Mice were raised according to the grouping, dosage and test method in Animal Experiment 1. After continuous administration for 21 days, each mouse was intraperitoneally injected with 1 mL of 20% chicken red blood cell suspension. After 30 minutes, the mice were killed by cervical dislocation and fixed on a mouse board in a supine position. The abdominal wall skin was cut in the middle, 2 mL of normal saline was injected, the mouse board was rotated for 1 minute, 1 mL of peritoneal washing fluid was aspirated, and dropped on 2 slides. After incubation at 37°C for 30 minutes, it was rinsed with normal saline and dried, and then fixed with acetone methanol solution (volume ratio 1:1) for 5 minutes, and then stained with 4% Giemsa-phosphate buffer for 3 minutes, rinsed with distilled water and dried, and then examined with an oil immersion microscope. The phagocytosis percentage and phagocytosis index were calculated according to the following formula:

[0106] Phagocytic percentage (%) = macrophages phagocytosing chicken red blood cells / number of macrophages counted × 100%;

[0107] Phagocytic index = total number of phagocytic chicken erythrocytes / number of counted macrophages.

[0108] 4. Results of Animal Experiment 2

[0109] The effect of the Chinese medicine compound extract of the present invention on the phagocytic ability of mouse peritoneal macrophages is shown in Table 2. Variance analysis shows that compared with the blank control group, the phagocytic rate and phagocytic index of the peritoneal macrophages of the model group mice on chicken red blood cells are extremely significantly reduced (p about 0.01); compared with the model group, the phagocytic rate and phagocytic index of the peritoneal macrophages of the Chinese medicine control group, T-1 group, T-2 group and T-3 group on chicken red blood cells are extremely significantly increased (p about 0.01); the phagocytic rate and phagocytic index of the peritoneal macrophages of the T-1 group, T-2 group and T-3 group on chicken red blood cells are extremely significantly higher than those of the Chinese medicine control group (p about 0.01).

[0110] Table 2 Effects of Chinese herbal compound extracts on the phagocytic ability of peritoneal macrophages

[0111]

[0112] Note: Compared with the model group, *p is about 0.05, **p is about 0.01; compared with the Chinese medicine control group, #p is about 0.05, ##p is about 0.01.

[0113] From the results of the above animal experiments 1 and 2, it can be seen that the model group has extremely significant differences in various indicators compared with the blank control group (p about 0.01), indicating that the immunosuppression model was successfully constructed; T-1 group, T-2 group and T-3 group have extremely significant differences compared with the model group (p about 0.01), indicating that the Chinese medicine compound extracts in the present invention can significantly improve the immune ability of mice; T-1 group, T-2 group and T-3 group have significant differences compared with the Chinese medicine control group (p about 0.05), indicating that the effect of the Chinese medicine extracts in the present invention on improving immunity is significantly stronger than that of the Chinese medicine control group. It can be seen that after replacing the Chinese medicines "prepared rehmannia" and "atractylodes macrocephala" with "polygonatum sibiricum" and "peony", the effect of improving immunity can be significantly improved, and this result belongs to the technical effect that those skilled in the art could not expect according to the prior art.

[0114] The description of the above embodiments is only used to understand the method and core idea of ​​the present invention. It should be pointed out that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principle of the present invention, and these improvements and modifications will also fall within the scope of protection of the claims of the present invention.

Claims

1. A Chinese herbal compound extract for improving the immune activity of the body, characterized in that: The traditional Chinese medicine compound extract is composed of codonopsis pilosula, astragalus, polygonatum, peony root, chuanxiong, jujube, liquorice and cinnamon bark.

2. The Chinese herbal compound extract according to claim 1, characterized in that: The Chinese medicine compound extract consists of the following components in parts by weight: 10-30 parts of Codonopsis pilosula, 10-30 parts of Astragalus membranaceus, 10-40 parts of Polygonatum sibiricum, 5-15 parts of Paeonia lactiflora, 5-15 parts of Chuanxiong, 1-10 parts of jujube, 2-10 parts of Licorice, and 2-8 parts of cinnamon.

3. The Chinese medicine compound extract according to claim 2, characterized in that: The Chinese medicine compound extract consists of the following components in parts by weight: 12-28 parts of Codonopsis pilosula, 12-28 parts of Astragalus membranaceus, 12-38 parts of Polygonatum sibiricum, 6-14 parts of Paeonia lactiflora, 6-14 parts of Chuanxiong, 2-8 parts of jujube, 2-8 parts of liquorice and 2-7 parts of cinnamon.

4. The Chinese herbal compound extract according to claim 3, characterized in that: The Chinese medicine compound extract is composed of the following components by weight: 14-24 parts of Codonopsis pilosula, 16-24 parts of Astragalus, 16-36 parts of Polygonatum sibiricum, 8-12 parts of Paeonia lactiflora, 8-12 parts of Chuanxiong, 2-6 parts of jujube, 4-6 parts of Licorice, and 2-6 parts of Cinnamon; Optionally, the Chinese medicine compound extract is composed of the following components in parts by weight: 20 parts of Codonopsis pilosula, 20 parts of Astragalus, 20 parts of Polygonatum sibiricum, 10 parts of Peony, 10 parts of Chuanxiong, 5 parts of Jujube, 5 parts of Licorice, and 3 parts of Cinnamon; Optionally, the Chinese medicine compound extract is composed of the following components by weight: 15 parts of Codonopsis pilosula, 20 parts of Astragalus, 30 parts of Polygonatum sibiricum, 8 parts of Paeonia lactiflora, 8 parts of Chuanxiong, 2 parts of jujube, 4 parts of Licorice, and 6 parts of Cinnamon; Optionally, the Chinese medicine compound extract is composed of the following components in parts by weight: 14 parts of Codonopsis pilosula, 18 parts of Astragalus membranaceus, 24 parts of Polygonatum sibiricum, 8 parts of Paeonia lactiflora, 10 parts of Ligusticum chuanxiong, 6 parts of Jujube, 6 parts of Licorice, and 5 parts of Cinnamon.

5. A pharmaceutical preparation for improving the immune activity of an organism, characterized in that: The active ingredient of the pharmaceutical preparation is the Chinese herbal compound extract according to any one of claims 1 to 4.

6. The pharmaceutical preparation according to claim 5, characterized in that The pharmaceutical preparation comprises pharmaceutically or food-acceptable excipients; Optionally, the dosage form of the pharmaceutical preparation includes granules, tablets, pills, capsules, solutions or suspensions.

7. The method for preparing the Chinese herbal compound extract according to any one of claims 1 to 4, characterized in that: The method comprises the following steps: (1) taking the raw material of the Chinese herbal compound extract, crushing and sieving; (2) extracting by boiling and leaching with water 5-20 times the liquid-to-solid ratio or ethanol 80% or less by volume; (3) filtering each extract in step (2), combining and concentrating the extract to obtain a concentrated solution of the Chinese herbal compound extract according to any one of claims 1 to 4; (4) The concentrated solution in step (3) is vacuum dried or spray dried to obtain the dry powder of the Chinese herbal compound extract according to any one of claims 1 to 4.

8. The method according to claim 7, characterized in that The extraction conditions in step (2) are as follows: extraction times are 1 to 4 times, each time for 20 minutes to 180 minutes.

9. The method for preparing the pharmaceutical preparation according to claim 5 or 6, characterized in that: The method comprises the following steps: mixing the Chinese herbal compound extract according to any one of claims 1 to 4 with pharmaceutically or food-acceptable excipients to obtain the pharmaceutical preparation according to claim 5 or 6.

10. Use of the Chinese herbal compound extract according to any one of claims 1 to 4 or the pharmaceutical preparation according to claim 5 or 6 in the preparation of medicines, health products or foods for enhancing or improving the immune activity of the body.